| Literature DB >> 29295986 |
Nina Linde1,2,3, Maria Casanova-Acebes4, Maria Soledad Sosa1,2,5, Arthur Mortha4,6, Adeeb Rahman7, Eduardo Farias1,2, Kathryn Harper1,2, Ethan Tardio1,2, Ivan Reyes Torres4, Joan Jones8, John Condeelis8, Miriam Merad4,7, Julio A Aguirre-Ghiso9,10.
Abstract
Cancer cell dissemination during very early stages of breast cancer proceeds through poorly understood mechanisms. Here we show, in a mouse model of HER2+ breast cancer, that a previously described sub-population of early-evolved cancer cells requires macrophages for early dissemination. Depletion of macrophages specifically during pre-malignant stages reduces early dissemination and also results in reduced metastatic burden at end stages of cancer progression. Mechanistically, we show that, in pre-malignant lesions, CCL2 produced by cancer cells and myeloid cells attracts CD206+/Tie2+ macrophages and induces Wnt-1 upregulation that in turn downregulates E-cadherin junctions in the HER2+ early cancer cells. We also observe macrophage-containing tumor microenvironments of metastasis structures in the pre-malignant lesions that can operate as portals for intravasation. These data support a causal role for macrophages in early dissemination that affects long-term metastasis development much later in cancer progression. A pilot analysis on human specimens revealed intra-epithelial macrophages and loss of E-cadherin junctions in ductal carcinoma in situ, supporting a potential clinical relevance.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29295986 PMCID: PMC5750231 DOI: 10.1038/s41467-017-02481-5
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919